Effect of Positive End Expiratory Pressure (PEEP) on Cerebral Oxymetry During Laparoscopy
NCT ID: NCT01436812
Last Updated: 2013-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2011-09-30
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
zero end-expiratory pressure
not applying PEEP during operation just applying TV=IBW\*6-8ml IBW = (male; 50+0.91\[(Ht-cm)-152.4\], female; 45.5 +0.91\[(Ht-cm)-152.4\], RR 8-12/min,
positive end expiratory pressure
PEEP 0 cmH2O
positive end expiratory pressure
applying PEEP 10cmH2O during operation just applying TV=IBW\*6-8ml IBW = (male; 50+0.91\[(Ht-cm)-152.4\], female; 45.5 +0.91\[(Ht-cm)-152.4\], RR 8-12/min,
zero end-expiratory pressure
positive end expiratory pressure 0 cm H2O during peumoperitoneum
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
zero end-expiratory pressure
positive end expiratory pressure 0 cm H2O during peumoperitoneum
positive end expiratory pressure
PEEP 0 cmH2O
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gachon University Gil Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Youn Yi Jo
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hyun Jeong Kwak, MD.PhD
Role: STUDY_CHAIR
Gachon University Gil Medical Center
Youn Yi Jo, MD.PhD
Role: PRINCIPAL_INVESTIGATOR
Gachon University Gil Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gachon University Gil Hospital
Incheon, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GIRBA2551
Identifier Type: REGISTRY
Identifier Source: secondary_id
GIRBA2551
Identifier Type: -
Identifier Source: org_study_id